(147 days)
Not Found
No
The summary describes a physical dispensing pin and does not mention any software, algorithms, or AI/ML terms.
No
The device is used for dispensing and injecting fluids into IV systems, which is a supportive function in therapy rather than directly providing a therapeutic effect itself.
No
Explanation: The device is described as an "IV additive dispensing pin for aspiration from multi-dose containers or injection into IV systems." Its function is to transfer fluids, not to diagnose medical conditions or provide information for diagnosis.
No
The device description clearly states it is an "IV additive dispensing pin," which is a physical hardware component used for aspiration and injection. There is no mention of software as the primary or sole component.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is described as an "IV additive dispensing pin for aspiration from multi-dose containers or injection into IV systems." This describes a device used for the physical manipulation and transfer of substances within an IV system, not for the in vitro examination of specimens derived from the human body.
- Device Description: The description reinforces the intended use, stating it's for "aspiration from multidose containers or injection into IV systems (IV bag)." Again, this is a physical manipulation device.
- Lack of IVD Characteristics: The description does not mention any of the typical characteristics of an IVD, such as:
- Analyzing biological samples (blood, urine, tissue, etc.)
- Detecting or measuring substances in biological samples
- Providing information for diagnosis, monitoring, or screening of diseases or conditions.
- Predicate Device: The predicate device (K925401; I.V. Fluid Transfer Pin) also points towards a non-IVD device used for fluid transfer in IV systems.
Therefore, the Chemo Mini Spike Plus, as described, is a medical device used for drug delivery and fluid management within an IV system, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
IV additive dispensing pin for aspiration from multidose containers or injection into IV systems (IV bag)
Product codes
LHI
Device Description
The Chemo Mini is an IV additive dispensing pin for aspiration from multidose containers or injection into IV systems (IV bag).
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
All finished products are tested and must meet all required release specifications before distribution. The array of testing required for release include, but are not limited to; physical testing, visual examination (in process and finished product).
The physical testing is defined by Quality Control Test Procedure documents. These tests are established testing procedures and parameters which conform to the product design specifications.
The testing instruction records for each of the individually required procedures are approved, released, distributed and revised in accordance with document control cGMP"s.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 880.5440 Intravascular administration set.
(a)
Identification. An intravascular administration set is a device used to administer fluids from a container to a patient's vascular system through a needle or catheter inserted into a vein. The device may include the needle or catheter, tubing, a flow regulator, a drip chamber, an infusion line filter, an I.V. set stopcock, fluid delivery tubing, connectors between parts of the set, a side tube with a cap to serve as an injection site, and a hollow spike to penetrate and connect the tubing to an I.V. bag or other infusion fluid container.(b)
Classification. Class II (special controls). The special control for pharmacy compounding systems within this classification is the FDA guidance document entitled “Class II Special Controls Guidance Document: Pharmacy Compounding Systems; Final Guidance for Industry and FDA Reviewers.” Pharmacy compounding systems classified within the intravascular administration set are exempt from the premarket notification procedures in subpart E of this part and subject to the limitations in § 880.9.
0
3/23/99
II 510(k) Summary of Safety and Effectiveness in Accordance with SMDA'90
RIOF2
B. Braun Medical, Inc 824 Twelfth Avenue Bethlehem. PA 18018 (610)691-5400
September 28, 1998 K983794
Contact: Mark S. Alsberge, Regulatory Affairs Director
- Product Name: Chemo Mini Spike Plus
Chemo Mini Spike Plus Trade Name:
Classification name:
General Hospital Class II. 80LHI 21 CFR 880.5440
SUBSTANTIAL EQUIVALENCE TO:
| ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ | ||
|---|---|---|
| 4075AL | Inc |
Device Description:
In accordance with section 510(k) for the Federal Food, Drug, and Cosmetic Act, B. Braun Medical, Inc. intends to introduce into interstate commerce the Chemo Mini is an IV additive dispensing pin for aspiration from multidose containers or injection into IV systems (IV bag).
Material:
The Chemo Mini Spike Plus is composed of materials that have been tested in accordance with the EN Standard 30993 and have been determined to be suitable for the intended use of this product.
1 The term "substantially equivalent" as use herein is intended to be a determination of substantial equivalence from an FDA -regulatory point of view under the Federal Food, Drug, and Cosmetic Act and relates to the fact that the product can be marketed without premarket approval or reclassification. These products may be considered distinct from a patent point of view. The term "substantially equivalent" is not applicable to and does not diminish any patent claims related to this product or the technology used to manufacture the product.
1
Substantial equivalence:
Image /page/1/Picture/1 description: The image shows handwritten text. The first line reads "K983794". The second line reads "P. 2 of 2". The text appears to be written with a black pen on white paper.
The Chemo Mini Spike Plus is similar in materials, form and intended use to the I.V. Fluid Transfer Pin currnetly marketed by B. Braun Medical, Inc. and cleared under K925401. There are no new issues of safety or effectiveness raised by Chemo Mini Spike Plus.
Safety And Effectiveness:
All finished products are tested and must meet all required release specifications before distribution. The array of testing required for release include, but are not limited to; physical testing, visual examination (in process and finished product).
The physical testing is defined by Quality Control Test Procedure documents. These tests are established testing procedures and parameters which conform to the product design specifications.
The testing instruction records for each of the individually required procedures are approved, released, distributed and revised in accordance with document control cGMP"s.
2
Image /page/2/Picture/1 description: The image shows the logo for the Department of Health & Human Services - USA. The logo is a circle with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of an eagle. The eagle is facing to the right and has three lines representing its wings.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
MAR 2 3 1999
Mr. Mark S. Alsberge Regulatory Affairs Director B. Braun Medical, Incorporated 901 Marcon Boulevard Allentown, Pennsylvania 18103-9341
Re : K983794 Chemo Mini Spike Plus Trade Name: Regulatory Class: II Product Code: LHI February 10, 1999 Dated: Received: February 16, 1999
Dear Mr. Alsberge:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Good Manufacturing Practice for Medical Devices: General (GMP) regulation (21 CFR Part 820) and that, through periodic GMP inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of
3
Page 2 - Mr. Alsberge
the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4692. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
Susan Lumpe
&Timothy A. Ulatowski Director Division of Dental, Infection Control, and General Hospital Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
510(k) Number (if known):
Plus Mini Spike lemo Device Name: Indications For Use: aspiration IV additive dispensing Ho injection containers multi-dose Ur trom sfems TV into
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Paltric Cucenta
(Division Sign-Off)
Division of Dental, Infection Control, and General Hospital Devices 510(k) Number
Prescription Use
(Per 21 CFR 801.109)
OR
Over-The-Counter Use .
(Optional Format 1-2-96)